Cargando…

Contrast Enhancement in MRI Using Combined Double Action Contrast Agents and Image Post-Processing in the Breast Cancer Model

Gd- and Fe-based contrast agents reduce T(1) and T(2) relaxation times, respectively, are frequently used in MRI, providing improved cancer detection. Recently, contrast agents changing both T(1)/T(2) times, based on core/shell nanoparticles, have been introduced. Although advantages of the T(1)/T(2...

Descripción completa

Detalles Bibliográficos
Autores principales:	MacDonald, David, van Veggel, Frank C. J. M., Tomanek, Boguslaw, Blasiak, Barbara
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10142138/ https://www.ncbi.nlm.nih.gov/pubmed/37109931 http://dx.doi.org/10.3390/ma16083096

Ejemplares similares

Contrast agents for hepatic MRI
por: Morana, Giovanni, et al.
Publicado: (2007)

MRI Contrast Agents in Glycobiology
por: Geraldes, Carlos F. G. C., et al.
Publicado: (2022)

MRI Contrast Agents for Pharmacological Research
por: Terreno, Enzo, et al.
Publicado: (2015)

Magnetic Nanomaterials as Contrast Agents for MRI
por: Caspani, Sofia, et al.
Publicado: (2020)

Magnetic Nanoparticles as MRI Contrast Agents
por: Avasthi, Ashish, et al.
Publicado: (2020)

Glycosaminoglycans and Contrast Agents: The Role of Hyaluronic Acid as MRI Contrast Enhancer
por: Ponsiglione, Alfonso Maria, et al.
Publicado: (2020)

Early detection of osteoarthritis in rabbits using MRI with a double-contrast agent
por: Onishi, Okihiro, et al.
Publicado: (2018)

Predicting post-contrast information from contrast agent free cardiac MRI using machine learning: Challenges and methods
por: Abdulkareem, Musa, et al.
Publicado: (2022)

MRI contrast agents: from molecules to particles
por: Laurent, Sophie, et al.
Publicado: (2017)

Correction to: Magnetic Nanoparticles as MRI Contrast Agents
por: Avasthi, Ashish, et al.
Publicado: (2021)

Cyclodextrins: promising scaffolds for MRI contrast agents
por: Sembo-Backonly, Berthe Sandra, et al.
Publicado: (2021)

Mn-Based MRI Contrast Agents: An Overview
por: Henoumont, Céline, et al.
Publicado: (2023)

Is the Transport of a Gadolinium-Based Contrast Agent Decreased in a Degenerated or Aged Disc? A Post Contrast MRI Study
por: Tibiletti, Marta, et al.
Publicado: (2013)

Gadonanotubes as new high-performance MRI contrast agents
por: Sitharaman, Balaji, et al.
Publicado: (2006)

Biocompatible Nanocomplexes for Molecular Targeted MRI Contrast Agent
por: Chen, Zhijin, et al.
Publicado: (2009)

Iron Oxide as an MRI Contrast Agent for Cell Tracking
por: Korchinski, Daniel J., et al.
Publicado: (2015)

Multiwalled carbon nanotube hybrids as MRI contrast agents
por: Kuźnik, Nikodem, et al.
Publicado: (2016)

A scale to measure MRI contrast agent sensitivity
por: Alvares, Rohan D. A., et al.
Publicado: (2017)

A Photocleavable Contrast Agent for Light-Responsive MRI
por: Reeßing, Friederike, et al.
Publicado: (2020)

Cerebrovascular MRI in the mouse without an exogenous contrast agent
por: Fouquet, Jérémie P., et al.
Publicado: (2019)

Combining arterial blood contrast with BOLD increases fMRI intracortical contrast
por: Priovoulos, Nikos, et al.
Publicado: (2023)

Impact of contrast agent injection duration on dynamic contrast‐enhanced MRI quantification in prostate cancer
por: Klawer, Edzo M.E., et al.
Publicado: (2018)

Development of an MRI contrast agent for both detection and inhibition of the amyloid-β fibrillation process
por: Utomo, Rohmad Yudi, et al.
Publicado: (2022)

Dynamic, Simultaneous Concentration Mapping of Multiple MRI Contrast Agents with Dual Contrast - Magnetic Resonance Fingerprinting
por: Anderson, Christian E., et al.
Publicado: (2019)

Tumor-Attentive Segmentation-Guided GAN for Synthesizing Breast Contrast-Enhanced MRI Without Contrast Agents
Publicado: (2022)

Biocompatible Polyhydroxyethylaspartamide-based Micelles with Gadolinium for MRI Contrast Agents
por: Jeong, Sang Young, et al.
Publicado: (2010)

Modified Gadonanotubes as a promising novel MRI contrasting agent
por: Jahanbakhsh, Rouzbeh, et al.
Publicado: (2013)

Effects of Substituents on the Properties of Metal-Free MRI Contrast Agents
por: Shiraishi, Ryoma, et al.
Publicado: (2019)

The potential toxic impact of different gadolinium-based contrast agents combined with 7-T MRI on isolated human lymphocytes
por: Friebe, Björn, et al.
Publicado: (2018)

Quantitative evaluation of contrast agent uptake in standard fat‐suppressed dynamic contrast‐enhanced MRI examinations of the breast
por: Kousi, Evanthia, et al.
Publicado: (2017)

Preparation of Hydrothermal Carbon Quantum Dots as a Contrast Amplifying Technique for the diaCEST MRI Contrast Agents
por: Pandey, Shalini, et al.
Publicado: (2022)

MRI with hepatobiliary contrast
por: Jhaveri, Kartik S
Publicado: (2015)

Ultrasound contrast agents
por: Ignee, Andre, et al.
Publicado: (2016)

To Contrast or Not to Contrast? On the Role of Contrast Enhancement in Hand MRI Studies of Patients with Rheumatoid Arthritis
por: Frenken, Miriam, et al.
Publicado: (2022)

In-Vivo Imaging of Cell Migration Using Contrast Enhanced MRI and SVM Based Post-Processing
por: Weis, Christian, et al.
Publicado: (2015)

Liver-specific agents for contrast-enhanced MRI: role in oncological imaging
por: Thian, Yee Liang, et al.
Publicado: (2013)

Fluorine-19 MRI Contrast Agents for Cell Tracking and Lung Imaging
por: Fox, Matthew S., et al.
Publicado: (2016)

Magnetic core–shell nanowires as MRI contrast agents for cell tracking
por: Martínez-Banderas, Aldo Isaac, et al.
Publicado: (2020)

Low-Molecular-Weight Fe(III) Complexes for MRI Contrast Agents
por: Chen, Shangjun, et al.
Publicado: (2022)

A robust MRI contrast agent for specific display of the interstitial stream
por: Zhou, Xiaohan, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_m6u4bh7qvmc5oke4ntki2tnk41